Klaus Hütter

559 total citations
10 papers, 486 citations indexed

About

Klaus Hütter is a scholar working on Pharmacology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Klaus Hütter has authored 10 papers receiving a total of 486 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 5 papers in Molecular Biology and 4 papers in Organic Chemistry. Recurrent topics in Klaus Hütter's work include Microbial Natural Products and Biosynthesis (9 papers), Plant Pathogens and Fungal Diseases (3 papers) and Carbohydrate Chemistry and Synthesis (3 papers). Klaus Hütter is often cited by papers focused on Microbial Natural Products and Biosynthesis (9 papers), Plant Pathogens and Fungal Diseases (3 papers) and Carbohydrate Chemistry and Synthesis (3 papers). Klaus Hütter collaborates with scholars based in Germany. Klaus Hütter's co-authors include Axel Zeeck, Ralf Thiericke, Susanne Grabley, H. Kluge, Joachim Wink, Reinhard Kirsch, Peter Hammann, Marion Mayer, E. Granzer and G. Bach and has published in prestigious journals such as The Journal of Antibiotics and Liebigs Annalen der Chemie.

In The Last Decade

Klaus Hütter

10 papers receiving 452 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Klaus Hütter Germany 9 296 243 179 116 32 10 486
HAMAO UMEZAWA Japan 11 178 0.6× 132 0.5× 269 1.5× 79 0.7× 27 0.8× 24 447
Youichi Uosaki Japan 14 179 0.6× 147 0.6× 274 1.5× 69 0.6× 21 0.7× 25 473
Tanya R. Johnson United States 9 179 0.6× 94 0.4× 208 1.2× 102 0.9× 36 1.1× 11 385
Cun-Heng He United States 13 270 0.9× 93 0.4× 152 0.8× 115 1.0× 28 0.9× 21 566
Tohru Yasuzawa Japan 17 397 1.3× 231 1.0× 376 2.1× 213 1.8× 34 1.1× 33 804
Gregory A. Fechner Australia 14 210 0.7× 108 0.4× 220 1.2× 167 1.4× 46 1.4× 23 509
Priscilla Offen United States 11 344 1.2× 130 0.5× 226 1.3× 171 1.5× 28 0.9× 15 578
Taro Amagata United States 11 134 0.5× 295 1.2× 139 0.8× 215 1.9× 11 0.3× 16 436
KOUICHI TSUCHIYA Japan 10 217 0.7× 171 0.7× 138 0.8× 127 1.1× 19 0.6× 14 369
Chad C. Stessman United States 9 196 0.7× 93 0.4× 172 1.0× 98 0.8× 29 0.9× 13 396

Countries citing papers authored by Klaus Hütter

Since Specialization
Citations

This map shows the geographic impact of Klaus Hütter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus Hütter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus Hütter more than expected).

Fields of papers citing papers by Klaus Hütter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Klaus Hütter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus Hütter. The network helps show where Klaus Hütter may publish in the future.

Co-authorship network of co-authors of Klaus Hütter

This figure shows the co-authorship network connecting the top 25 collaborators of Klaus Hütter. A scholar is included among the top collaborators of Klaus Hütter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klaus Hütter. Klaus Hütter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Bach, G., Susanne Grabley, Peter Hammann, et al.. (1993). Secondary Metabolites by Chemical Screening, 22. Gabosines, New Carba‐sugars From Streptomyces. Liebigs Annalen der Chemie. 1993(3). 241–250. 70 indexed citations
2.
Thiericke, Ralf, Susanne Grabley, Klaus Hütter, et al.. (1993). Secondary Metabolites by Chemical Screening, 23. Waraterpols, New Penicillium Metabolites and Their Derivatives. Liebigs Annalen der Chemie. 1993(5). 565–571. 30 indexed citations
4.
Grabley, Susanne, Peter Hammann, Klaus Hütter, et al.. (1992). SECONDARY METABOLITES BY CHEMICAL SCREENING. 20. Decarestrictines, a new family of inhibitors of cholesterol biosynthesis from Penicillium: III. Decarestrictines E to M.. The Journal of Antibiotics. 45(7). 1176–1181. 95 indexed citations
6.
Grabley, Susanne, Peter Hammann, Klaus Hütter, et al.. (1991). Secondary metabolites by chemical screening. Part 19. SM 196 A and B, novel biologically active angucyclinones from Streptomyces sp.. The Journal of Antibiotics. 44(6). 670–673. 29 indexed citations
7.
Grabley, Susanne, Klaus Hütter, Reinhard Machinek, et al.. (1991). Secondary metabolites by chemical screening, 10. Glycerinopyrin, a novel metabolite from Streptomyces violaceus. Liebigs Annalen der Chemie. 1991(1). 77–80. 7 indexed citations
8.
Henkel, Thomas, Axel Zeeck, Susanne Grabley, et al.. (1991). Secondary metabolites by chemical screening, 18. Narbosines, new carbohydrate metabolites from Streptomyces. Liebigs Annalen der Chemie. 1991(6). 575–580. 11 indexed citations
9.
Hütter, Klaus, et al.. (1989). Viriplanin A, a new anthracycline antibiotic of the nogalamycin group. II. The structure of a novel hydroxyamino sugar from reduced viriplanin A.. The Journal of Antibiotics. 42(1). 7–13. 14 indexed citations
10.
Hütter, Klaus, E. Baader, Axel Zeeck, et al.. (1986). Viriplanin A, a new anthracycline antibiotic of the nogalamycin group. I Isolation, characterization, degradation reactions and biological properties.. The Journal of Antibiotics. 39(9). 1193–1204. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026